Womens heart health series: A mini-symposium

Medical Science Monitor

Volumn 9, Issue 6, 2003, Pages

  McLarty, Allison ^a   Mann, Noelle ^a   Lawson, William ^a   Forster, Antoinette ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Coronary artery disease; Estrogen; Gender; Risk factors

Indexed keywords

ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE;

BREAST CANCER; CANCER MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL TRIAL; CONFERENCE PAPER; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DILATATION; DEPRESSION; DIABETES MELLITUS; DIAGNOSTIC TEST; FEMALE; HEALTH; HEART CATHETERIZATION; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; MENOPAUSE; PSYCHOSOCIAL CARE; SEX DIFFERENCE; SEX RATIO; SYMPTOM; TREATMENT INDICATION;

BREAST NEOPLASMS; CORONARY DISEASE; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; INCIDENCE; MALE; MENOPAUSE; SMOKING; UNITED STATES; WOMEN'S HEALTH;

EID: 0038168016     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (57)

1. National Center for Health Statistics
2. American Heart Association Biostatistical Fact Sheet, Women and Cardiovascular Diseases, 2002
3. New York State Department of Health Statistics and Reports
4. National Center for Chronic Disease Prevention and Health Promotion, Volume 14, No. 2, Spring Summer, 2001 http://www.cdc.gov/nccdphp/cdnr/cdnr_so0106.htm
5. Women and Heart Disease: AHRQ Publication No. 01-P016, September 2001. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/research/womhcart.htm
6. Dempsey SJ, Dracup K, Moser DK: Women's decision to seek care for symptoms of acute myocardial infarction. Heart and Lung, 1995; 24: 444-456
7. Mendelsohn ME, Karas RH: The protective effects of estrogen on the cardiovascular system. NEJM, 1999; 340: 1801-1811
8. Subbiah MTR: Mechanisms of cardioprotection by estrogens. Proceedings of the Society for Experimental Biology and medicine, 1998; 217: 23-29
9. Meische H, Larsen MP, Eisenberg MS: Gender differences in reported symptoms for acutre myocardial infarction; impact on prehospital delay time interval. American Journal of Emergency Medicine, 1998; 16: 463-366
10. Vogel RA: Coronary risk factors, endothelial function and atherosclerosis. Clin Cardiol, 1997; 20: 426-432
11. West of Scotland Coronary Prevention Study Group: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. NEJM, 1995; 333: 1301-1307
12. Scandinavian Simvastatin Study Group: Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease. Lancet, 1994; 344: 1383-1389
13. Lewis SJ, Sacks FM, Mitchell JS et al: Effect of pravastatin on cardiovascular events in women after myocardial infarction. JACC, 1998; 32(1): 140-6
14. Mayo Medical School: Exercise and its role in the prevention and rehabilitation of cardiovascular disease. Annals of Behavioral Med, 1997; 19(3): 220-229
15. Gaps persist ill heart disease. American Medical News, 2001
16. Mosca L et al: A guide to preventive cardiology for women. JACC, 1999; 33: 1751-1755
17. Mendelsohn ME, Karas RH: Estrogen and the blood vessel wall. Curr Opin Cardiol, 1994; 9: 619-26
18. Losordo DW, Kearney M, Kim EA et al: Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation, 1994; 89: 1501-1510
19. Stampfer M, Colditz G: estrogen replacement therapy and coronary artery disease: a quantitative assessment of the epidemiologic evidence. Prev med, 1991; 20: 47-63
20. Grady D, Rueben SB, Pettiti DB et al: Hormone therapy to prevent disease and prolong life in post menopausal women. Ann Intern Med, 1992; 117: 1016-1037
21. Hully S, Grady D, Bush T et al: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA, 1998; 280: 605-613
22. Roussow JE, Anderson GL, Prentice RL et al: Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA, 2002; 288: 321-333
23. Birdwell BG, Herbers JE, Kroenke K: Evaluating chest pain: the patient's presentation style alters the physician's diagnostic approach. Arch Intern Med, 1993; 153: 1991-5
24. DeSanctis RW: Clinical manifestations of coronary artery disease: Chest pain in women. In Wenger NK, Speroff L, Packard B (eds). Cardiovascular Health and Disease in Women, Greenwich, CT. Le Jacq Communications, 1993
25. Alexander KP, Shaw LJ, DeLong ER et al: Value of exercise treadmill testing in women. J Am Coll Cardiol, 1995; 32: 1657
26. Kwok Y, Kim C, Grady D et al: Meta-analysis of excrcise testing to detect coronary disease in women. Am J Card, 1999; 83: 660
27. Fleischmann KE, Hunink MGM, Kuntz KM, Douglas PS: Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance. JAMA, 1998; 280: 913
28. Tong AT, Douglas PS: Stress echocardiography in woman. Cardiol Clinic, 1999; 17: 573
29. Greuntzig AR: Tranluminal dilatation of cornnary artery stenosis. Lancet, 1978; 2: 263
30. Grines CI, Browne KF, Marco J et al: A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. NEJM, 1993; 328: 673-9
31. Stones CW, Grines CL, Browne KF et al: Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Acute Myocardial Infarction (PAM1) Trial. J Am Coll Card, 1995; 25: 370-7
32. Jacobs AK, Kelsey SF, Yeh W et al: Documentation of decline in morbidity in women undergoing coronary angioplasty (a report from the 1993-4 NHLBI Percotaneous Coronary Angioplasty Registry). Am J Cardiol, 1997; 80: 979-84
33. BARI investigators: Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. NEJM, 1996; 335: 217-35
34. BARI Investigators: Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. JACC, 2000; 35: 1122-9
35. Horlitz M, Sigwart U et al: Statins do not prevent restenosis after coronary angioplasty. Herz, 2000; 26(2): 119-28
36. Lytle BW, Cosgrove DM: Coronary artery bypass surgery. Curr Prob Surg, 1992; 29: 743
37. Glenn's Thoracic and Cardiovascular Surgery: Editor Baue AE. Appleton and Lange, Stamford, Connecticut, 1996; 2076
38. Cheng W, Denton T, Fontana G et al: Off-pump coronary surgery: effect on early mortality and stroke. J Thorac Cardiovasc Surg, 2002; 124: 313-319
39. Petro KR, Dullum MK, Garcia JM: Minimally invasive coronary revascularization in women. Heart Surgery Forum, 2000; 3(1): 41-6
40. Cartier R, Brann S et al: Systematic off-pump coronary artery revascularization in multivessel disease. J Thorac Cardiovasc Surg, 2000; 119: 221-229
41. Kirk KC, Aldridge RA et al: Coronary artery bypass grafting with and without cardiopulmonary bypass. J of Extra-Corporeal Technology, 2001; 33: 86-90
42. Drenth D, Winter J, Veeger N et al: Minimally invasive coronary artery bypass grafting versus percutaneous transluminal coronary angioplasty. J Thorac Cardiovasc Surg, 2002; 124: 130-135
43. Ferguson TB, Hammill BG, Peterson ED et al: A decade of change - risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999. Annals of Thoracic Surgery, 2002; 73(2): 480-489
44. Fisher L, Kennedy JW, Davis KB et al. Association of sex, physical size and operative mortality after coronary artery bypass. J Thorac Cardiovasc Surg, 1982; 84: 334-341
45. Jaglal SB, Tu J et al: Higher in-hospital mortality in female patients following coronary artery bypass surgery. Clin Invest Med, 1995; 18: 99-107
46. Bergelson BA, Tommaso CL: Gender differences in clinical evaluation and triage in coronary artery disease. CHEST, 1995; 108: 1510-13
47. Loop FD, Golding LR, Macmillan JP, Cosgrove DM et al: Coronary artery surgery in women compared to men. JACC, 1983; 1(2): 383-90
48. O'Connor GT, Morton JR, Diehl MJ et al: Differences between men and women in hospital mortality associated with coronary artery bypass graft surgery. Circulation, 1993; 88: 2104-2110
49. Edwards FH, Carey JS, Grover FL et al: Impact of gender on coronary bypass operative mortality. Annals of Thoracic Surgery, 1998; 66: 125-31
50. Vaccarino V, Abramson, JL et al: Sex differences in hospital mortality after coronary artery bypass surgery: evidence for a higher mortality in younger women. Circulation, 2002; 105(10): 1176-81
51. O'Keefe JII, Kim SC, Hall RR et al: Estrogen replacement therapy after coronary angioplasty in women. JACC, 1997; 29: 1-5
52. Sullivan JM, El-Zeky F, Zwaag RV et al: Effect on survival of estrogen replacement therapy after coronary artery bypass grafting. Am J Cardiol, 1997; 79: 847-850
53. Eaker ED: Psychosocial factors in the epedemiology of coronary heart disease in women. Psychiatric Clinics of North America, 1989; 12: 167-173
54. Rozanski A, Blumenthal J, Kaplan J: Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation, 1999; 99: 2192-2217
55. Jacobs SC, Sherwood JB: The cardiac psychology of women and coronary artery disease. In Allan and Scheidt (Eds.). Heart and Mind; pp 197-218. Washington DC, American Psychological Association, 1996
56. Plach K: Anxiety in women with heart disease. Psychiatric Times, 2002; 19(3): 1-9
57. Zabat-Zin J: Full Catastrophe living: using the wisdom of your body and mind to face stress, pain and illness. New York, NY 1990: Delacorte Press.